<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03803735</url>
  </required_header>
  <id_info>
    <org_study_id>GFAOP</org_study_id>
    <nct_id>NCT03803735</nct_id>
  </id_info>
  <brief_title>Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa</brief_title>
  <acronym>RFAOP</acronym>
  <official_title>French African Pediatric Oncology Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French Africa Pediatric Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gustave Roussy, Cancer Campus, Grand Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>French Africa Pediatric Oncology Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ultimate aim of this registry is to collect precise information concerning the children
      coming to oncology units working with the French African Oncology Group. This data will help
      to plan and provide correct pediatric oncology treatment and care for this population.

      Collecting the data will give much needed information on numbers, stage, treatment and
      outcome. The register will give data for local and national health authorities in planning
      pediatric cancer programs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This register is a registration of all children entering hospital based pediatric oncology
      units, working in selected hospitals in French speaking Africa. The data collected includes:
      demographic and socioeconomic status as well as clinical status and outcome.

      The register also collects information on vital status, treatment abandonment and loss to
      follow-up.

      Data, collected locally is entered on line using the Research Electronic Data Capture
      (REDCap) program. Data are stored under the responsibility of the IT department at Gustave
      ROUSSY in Paris- Villejuif.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Number of children with a suspicion of any type of cancer in a given unit</measure>
    <time_frame>in any 12 month period</time_frame>
    <description>Number of children with details of :
the type of cancer
the stage of the identified cancer coming into a given unit</description>
  </primary_outcome>
  <primary_outcome>
    <measure>VITAL STATUS:</measure>
    <time_frame>in any 12 month period</time_frame>
    <description>Dead or alive
The number of children living
the number of children dead</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Illness status</measure>
    <time_frame>in any 12 month period</time_frame>
    <description>The number of children relapsed,
The number of children whos illness has progressed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment Status</measure>
    <time_frame>in any 12 month period</time_frame>
    <description>The number of children who had treatment administered,
The number of children who abandoned treatment</description>
  </primary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Pediatric Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All childre with any pediatric cancer types, coming into any one of the participating units
        in a 12 month period.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Any child presenting at any one of the participating units for treatment

          2. Any child with any type of cancer

          3. Any child or adolescent less than 18 years of age.

        Exclusion Criteria:

          1. No cancer found

          2. Age greater than 18 years -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Brenda MALLON, MSC</last_name>
    <phone>+ 33142115411</phone>
    <email>brenda.mallon@gustaveroussy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Catherine PATTE, DR</last_name>
    <phone>+ 33142116560</phone>
    <email>catherine.patte@gustaveroussy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>GFAOP</name>
      <address>
        <city>Villejuif</city>
        <state>Paris</state>
        <zip>00094</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BRENDA MALLON, MSC</last_name>
      <phone>0033661519474</phone>
      <email>brenda.mallon@gustaveroussy.fr</email>
    </contact>
    <contact_backup>
      <last_name>CATHERINE PATTE, DR</last_name>
      <phone>0033142116560</phone>
      <email>catherine.patte@gustaveroussy.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>November 8, 2018</study_first_submitted>
  <study_first_submitted_qc>January 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2019</study_first_posted>
  <last_update_submitted>February 13, 2020</last_update_submitted>
  <last_update_submitted_qc>February 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Units have acess to their own data and can use it for reporting.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

